Evidence map›Paper›PMID 39591176›Full record

ArticleVaccines2024

Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer.

Robert D Marek, Selena Halabi, Mu-En Wang, Jason McBane, Junping Wei, Tao Wang, Xiao Yang, Congxiao Liu, Gangjun Lei, Herbert Kim Lyerly and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Androgens are a Key Factor Affecting Immune Related Diseases.The world journal of men's health · 2026
    Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Robert D MarekDepartment of Pathology, Duke University, Durham, NC 27710, USA.ORCID 0000-0001-5182-2811
Selena HalabiDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.ORCID 0009-0005-9308-0701
Mu-En WangDepartment of Pathology, Duke University, Durham, NC 27710, USA.ORCID 0000-0002-5953-3499
Jason McBaneDepartment of Surgery, Duke University, Durham, NC 27777, USA.ORCID 0009-0003-7955-3977
Junping WeiDepartment of Surgery, Duke University, Durham, NC 27777, USA.ORCID 0000-0001-6311-6033
Tao WangDepartment of Surgery, Duke University, Durham, NC 27777, USA.
Xiao YangDepartment of Surgery, Duke University, Durham, NC 27777, USA.ORCID 0009-0000-5228-6459
Congxiao LiuDepartment of Surgery, Duke University, Durham, NC 27777, USA.
Gangjun LeiDepartment of Surgery, Duke University, Durham, NC 27777, USA.ORCID 0000-0002-0505-0475
Herbert Kim LyerlyDuke Cancer Institute, Duke University, Durham, NC 2771, USA.ORCID 0000-0002-0063-4770
Ming ChenDepartment of Pathology, Duke University, Durham, NC 27710, USA.ORCID 0000-0002-3470-1062
Timothy N TrotterDepartment of Surgery, Duke University, Durham, NC 27777, USA.ORCID 0000-0002-4579-943X
Zachary C HartmanDepartment of Pathology, Duke University, Durham, NC 27710, USA.ORCID 0000-0001-6549-8207

Funding

Viral Oncology Training GrantT32CA009111 · NCI · DUKE UNIVERSITY · PI LUFTIG, MICAH A. · 1985 to 2023
$8.9M
Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancersR01CA238217 · NCI · DUKE UNIVERSITY · PI HARTMAN, ZACHARY CONRAD · 2020 to 2024
$2.4M
Targeting the Progesterone Receptor as a Novel Means to Increase Efficacy of Immune Checkpoint Inhibitors in Hormone Receptor Positive Breast CancerR21CA274044 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HAGAN, CHRISTY, HARTMAN, ZACHARY CONRAD · 2022 to 2023
$472k
NCI NIH HHS R01 CA238217NCI NIH HHS R21 CA274044NCI NIH HHS T32 CA009111NIH HHS 5R01-CA23821NIH HHS 5T32-CA009111-45ZCH 1R21CA274044-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

androgen receptorcastration resistanceimmune checkpoint inhibitionimmune suppressionprostate cancervaccines

Identifiers

PMID39591176
PMCPMC11599078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.